- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06675370
The Glittre Activities of Daily Living Test in Chronic Low Back Pain
July 8, 2025 updated by: Merve Firat, Kirsehir Ahi Evran Universitesi
Validity and Reliability of the Glittre Activities of Daily Living Test for Assessing Functional Status in Individuals With Chronic Low Back Pain
The aim of our study is to investigate the validity and reliability of the Glittre activities of daily living test in individuals with chronic low back pain.
Study Overview
Status
Completed
Conditions
Study Type
Observational
Enrollment (Actual)
42
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Kirsehir, Turkey
- Kirşehir Ahi Evran University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Individuals with chronic low back pain who are being followed up at the Department of Physical Medicine and Rehabilitation at Kirsehir Ahi Evran University will be included in the study.
Description
Inclusion Criteria:
- Diagnosed with chronic low back pain
- Chronic low back pain for at least the last 3 months
- Being aged 18-65
- Voluntary participation in the study
Exclusion Criteria:
- Having orthopedic or neurological impairments
- History of surgery due to chronic low back pain in the last 6 months
- Being pregnant
- Participating in regular physical activity in the past 3 months
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Indıviduals with chronic low back pain
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Daily living activities
Time Frame: 20 minutes
|
It will be evaluated with the Glittre activities of daily living test
|
20 minutes
|
|
Exercise capacity
Time Frame: 10 minutes
|
It will be evaluated with 6 minute walk test.
|
10 minutes
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Musle function
Time Frame: 1 minute
|
It will be assessed with a one-minute sit-stand test.
|
1 minute
|
|
Functional mobility
Time Frame: 1 minute
|
This will be evaluated with a timed up and go test.
|
1 minute
|
|
Disability level
Time Frame: 5 minutes
|
It will be assessed with Oswestry Disability Index.
High scores on the scale indicate the presence and severity of symptoms.
|
5 minutes
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Merve Firat, Kirşehir Ahi Evran University
- Study Chair: Basak Kavalci Kol, Kirşehir Ahi Evran University
- Study Chair: Figen Tuncay, Kirşehir Ahi Evran University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 5, 2024
Primary Completion (Actual)
May 30, 2025
Study Completion (Actual)
July 8, 2025
Study Registration Dates
First Submitted
November 4, 2024
First Submitted That Met QC Criteria
November 4, 2024
First Posted (Actual)
November 5, 2024
Study Record Updates
Last Update Posted (Actual)
July 9, 2025
Last Update Submitted That Met QC Criteria
July 8, 2025
Last Verified
November 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2024-14/121
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.